Skip to content

Evaluation of the effectiveness of inhaled furosemide in patients with acute asthma attack

Evaluation of the effectiveness of inhaled furosemide in patients with acute asthma attack

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180522039784N2
Enrollment
90
Registered
2021-11-25
Start date
2021-12-22
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

???. Asthma

Interventions

Intervention 1: Intervention group: In the intervention group, patients, in addition to oxygen, received salbutamol with a dose of 5 mg and Frosemide with a dose of 40 mg with nebuliser Mask.Patients

Sponsors

Karaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Satisfaction to participate in the study Asthma diagnosis The incidence of mild to moderate asthma attack (the clinical criterion of asthma 1 to 6) Ability to perform respiratory tests

Exclusion criteria

Exclusion criteria: Start over 10 hours of symptoms History of smoking over 10 pack-year Simultaneous acute illness Pregnancy Beta 2 agonist consumption in 6 hours before referral Pneumonia

Design outcomes

Primary

MeasureTime frame
First second of forced expiration. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: Bionet SPM-7 Spirometr device.;Peak expiratory flow rate. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: Bionet SPM-7 Spirometr device.

Secondary

MeasureTime frame
Heart rate. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: The heart rate per minute by examination.;Respiratory rate. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: The respiratory rate per minute by examination.;Clinical criteria of asthma. Timepoint: Before starting treatment, 15, 30 and 45 minutes. Method of measurement: Clinical Criterion of Asthma (CAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDariush Shiri

Karaj University of Medical Sciences

d.shiri@abzums.ac.ir0098 26 343434

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026